Flurry of Announcements Sends Salix Shares SoaringWRAL.com, NC - 22 hours agoSalix also disclosed a co-promotion agreement with Eisai, which will utilize some 600 sales representatives to promote the Salix product Colazal. …Salix Pharmaceuticals Acquires Patent-Protected Metoclopramide-Zydis ® Business Wire (press release)all 13 news articles
Read full story
Aricept(R) Receives Approval for Additional Efficacy and DosagePipelineReview.com (press release), Spain - Aug 24, 2007Eisai Co., Ltd. today announced that the company received approval for additional efficacy and dosage of Aricept® (donepezil hydrochloride) for the …
Read full story
RTT NewsSalix Pharmaceuticals Announces Co-Promotion Agreement for BalsalazideBusiness Wire (press release), CA - 6 hours agoWe believe the Eisai co-promotion will significantly increase the reach and frequency of our “COLAZAL message.” Additionally, we believe the Eisai primary …Salix Pharma Completes Phase IIb Trial Of Rifaximin And Phase III … RTT NewsSalix shares surge on Eisai deal News & ObserverSalix Pharmaceuticals Acquires Patent-Protected Metoclopramide-Zydis® Carolina Newswire (press release)PharmaLive.com (press release)all 266 news articles
Read full story
Sanko Junyaku and Eisai to Co-promote “Picolumi ucOC”, Diagnostic …PharmaLive.com (press release), PA - Aug 23, 2007The Picolumi® ucOC will be introduced to the market on August 23, 2007, in co-promotion with Eisai Co., Ltd. The Picolumi® ucOC is a new in vitro diagnostic …
Read full story
Eisai Announces New Hires and PromotionsPharmaLive.com (press release), PA - Aug 17, 2007(Research Triangle Park, NC) Eisai Inc. is a US pharmaceutical subsidiary of Eisai Co., Ltd., a research-based human health care (hhc) company that …
Read full story
JAPAN'S EISAI PUSHES FOR DEVELOPMENT OF CANCER DRUGSTherapeutics Daily (subscription) (press release), PA - Aug 25, 2007TOKYO, Aug 24 Asia Pulse - Japanese pharmaceutical firm Eisai Co. (TSE:4523) is accelerating its development of antibody drugs, hoping to leverage the …
Read full story
Market Spotlight: Heartburn DrugsForbes, NY - Aug 22, 2007… Protonix manufacturer Wyeth, and Japan's Eisai Co., which makes Aciphex, and markets it with Ortho-McNeil Inc. in the United States. …
Read full story
Aricept Receives Approval for Additional Efficacy and Dosage For …PharmaLive.com (press release), PA - Aug 23, 2007Aricept®, an acetylcholinesterase inhibitor developed by Eisai Co., Ltd., is the only approved prescription medicine for the treatment AD in Japan. …
Read full story
UK Must Change Alzheimer's Drug AdviceWashington Post, United States - Aug 10, 2007Drug companies Eisai Co. Ltd. and Pfizer Inc., along with the Alzheimer's Society, challenged NICE's decision. In a statement, Eisai and Pfizer said the …
Read full story
UPDATE 3-UK court upholds Alzheimer's drug restrictionsReuters.uk, UK - Aug 10, 2007Japan's Eisai Co. Ltd. (4523.T: Quote, NEWS , Research), which markets top-selling Alzheimer's medicine Aricept with Pfizer Inc. (PFE. …
Read full story
AstraZeneca's Nexium on displayBloomberg - Aug 9, 2007Similar drugs include Aciphex, from Eisai Co., Prevacid, produced by a joint venture of Abbott Laboratories and Takeda Pharmaceutical Co. and Protonix, …
Read full story
UPDATE:UK Court Rules Against Detail Of NICE Alzheimer's PolicyCNNMoney.com - Aug 10, 2007LONDON -(Dow Jones)- Japanese drugmaker Eisai Co. Ltd. (ESALY) Friday said it had partly won its legal case against the UK National Institute for Health and …
Read full story
Eisai Says NICE Loses Alzheimer's Drugs Judicial ReviewCNNMoney.com - Aug 10, 2007LONDON -(Dow Jones)- Japanese drugmaker Eisai Co Ltd. (ESALY) Friday said a UK court has ruled that the National Institute for Health and Clinical …
Read full story
Iconix Releases On-Line Version of World's Largest Toxicogenomic …CNNMoney.com - Aug 14, 2007… Abbott Laboratories, ICOS, Eli Lilly, Schering-Plough , AstraZeneca, Taisho Pharmaceutical Co., Ltd., Eisai Co., Ltd. and other leading companies. …
Read full story
Japan Outlook: Hitachi, Mazda, NEC, Tepco 1Q; June JoblessFXstreet.com The Foreign Exchange Market, Spain - Jul 30, 2007TO) 0300 - Sumitomo Chemical Co. (4005.TO) 0400 - Mitsubishi Chemical Holdings Corp. (4188.TO) - Sekisui Chemical Co. (4204.TO) - Eisai Co. (4523. …
Read full story
REFILE-UPDATE 3-Takeda profit rises 5 percent, outlook unchangedReuters - Jul 31, 2007T: Quote, NEWS , Research) and Eisai Co. Ltd. (4523.T: Quote, NEWS , Research) also posted strong first-quarter results on bumper sales of their flagship …
Read full story
UPDATE 3-Takeda profit rises 5 percent, outlook unchangedReuters.uk, UK - Jul 31, 2007T: Quote, NEWS , Research) and Eisai Co. Ltd. (4523.T: Quote, NEWS , Research) also posted strong first-quarter results on bumper sales of their flagship …
Read full story
Top Products Help ProfitWall Street Journal - Jul 31, 2007Eisai Co., maker of Aricept for Alzheimer's disease, said net profit in its fiscal first quarter rose 22% to 19.34 billion yen. Group sales climbed 14% to …UPDATE 2-Takeda profit rises 5 percent, outlook unchanged Reutersall 41 news articles
Read full story
Astellas posts strong Q1, trims European operationsReuters - Aug 1, 2007T: Quote, Profile, Research) and Eisai Co. Ltd. (4523.T: Quote, Profile, Research), which all benefited from strong sales of their mainstay drugs overseas. …
Read full story
ASIA MARKETS Asian markets volatile on credit market concernsMarketWatch - 10 hours ago… with Japanese shares ending higher on gains in exporters such as Canon Inc. and Eisai Co. while shares in Hong Kong and South Korea surrendered early …
Read full story